Mitarbeiter: 03 (2023.0)Rechtsform: 5485Größe: PMEGründungsdatum: 2004-03-28 (22 Jahre)Status: AktivBranche: Commerce de détail de produits pharmaceutiques en magasin spécialiséStandort: ROCROI (08230), Ardennes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE RACOUR DEPREUVE is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ROCROI (08230),
this company of category PME
shows in 2023 a revenue of 2.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
In 2025, SELARL PHARMACIE RACOUR DEPREUVE generates positive net income of 22 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 78 k€ -> 22 k€.
Nettoergebnis (2025)
?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Le compte de résultat détaillé n'est pas disponible pour cette entreprise (liasse simplifiée ou données confidentielles).
Évolution graphique
Anzeigen :
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Aktiva
Chargement des données...
Poste
Brutto
Abschr.
Netto
%
Entwicklung
Données de bilan actif non disponibles pour cette entreprise
Passiva
Chargement des données...
Poste
Jahr
%
Entwicklung
Données de bilan passif non disponibles pour cette entreprise
Solvenz- und Verschuldungskennzahlen
The debt ratio (= Financial debt / Equity x 100) stands at 3%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 85%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Verschuldungsgrad (2025)
?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible 50-100% : Moderat > 100% : Hoch
3.075%
Finanzielle Autonomie (2025)
?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Entwicklung der Solvenzkennzahlen SELARL PHARMACIE RACOUR DEPREUVE
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Kennzahl
2017
2018
2019
2020
2021
2022
2023
2024
2025
Verschuldungsgrad
0.0
0.0
2.822
22.113
18.649
14.084
5.932
5.155
3.075
Finanzielle Autonomie
60.755
69.611
65.597
70.482
72.208
74.214
81.565
84.232
84.999
Rückzahlungsfähigkeit
None
None
None
None
None
None
2.312
None
None
Cashflow / Umsatz
None%
None%
None%
None%
None%
None%
1.765%
None%
None%
Positionnement sectoriel
Debt ratio
3.082025
2023
2024
2025
Q1: 13.57
Méd: 49.47
Q3: 128.28
Excellent
In 2025, the debt ratio of SELARL PHARMACIE RACOUR D... (3.08) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
85.0%2025
2023
2024
2025
Q1: 33.69%
Méd: 53.88%
Q3: 72.26%
Excellent+10 pts über 3 Jahre
In 2025, the financial autonomy of SELARL PHARMACIE RACOUR D... (85.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
2.31 years2023
2023
Q1: 0.95 years
Méd: 3.58 years
Q3: 7.48 years
Good
In 2023, the repayment capacity of SELARL PHARMACIE RACOUR D... (2.31) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquiditätskennzahlen
The liquidity ratio (= Current assets / Current liabilities) stands at 174.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquiditätsquote (2025)
?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut 1-1.5 : Angemessen < 1 : Risque de liquidité
173.998
Entwicklung der Liquiditätskennzahlen SELARL PHARMACIE RACOUR DEPREUVE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Kennzahl
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquiditätsquote
126.048
100.525
98.578
210.574
192.368
186.246
173.562
198.377
173.998
Zinsdeckung
None
None
None
None
None
None
2.731
None
None
Positionnement sectoriel
Liquidity ratio
174.02025
2023
2024
2025
Q1: 131.48
Méd: 182.6
Q3: 258.72
Average
In 2025, the liquidity ratio of SELARL PHARMACIE RACOUR D... (174.00) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
2.73x2023
2023
Q1: 0.38x
Méd: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of SELARL PHARMACIE RACOUR D... (2.7x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Umlaufvermögensbedarf und Zahlungsfristen
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operatives Working Capital (2025)
?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität
0 j
Lagerumschlag (2025)
?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag
0 j
Entwicklung des Working Capital und der Zahlungsfristen SELARL PHARMACIE RACOUR DEPREUVE
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Kennzahl
2017
2018
2019
2020
2021
2022
2023
2024
2025
BFR d'exploitation
0 €
0 €
0 €
0 €
0 €
0 €
398 569 €
0 €
0 €
Lagerumschlag (Tage)
0
0
0
0
0
0
44
0
0
Crédit clients (jours)
0
0
0
0
0
0
16
0
0
Crédit fournisseurs (jours)
0
0
0
0
0
0
42
0
0
Positionnement de SELARL PHARMACIE RACOUR DEPREUVE dans son secteur
Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé
Bewertungsschätzung
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE RACOUR DEPREUVE is estimated at
346 009 €
(range 234 803€ - 542 936€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
234k€346k€542k€
346 009 €Range: 234 803€ - 542 936€
NAF 5 année 2025
Valuation method used
Net Income Multiple
21 782 €
×
15.9x
=346 010 €
Range: 234 804€ - 542 937€
Only this financial indicator is available for this company.
Bewertungsentwicklung
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE RACOUR DEPREUVE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE RACOUR DEPREUVE
What is the revenue of SELARL PHARMACIE RACOUR DEPREUVE ?
The revenue of SELARL PHARMACIE RACOUR DEPREUVE in 2023 is 2.3 M€.
Is SELARL PHARMACIE RACOUR DEPREUVE profitable?
Yes, SELARL PHARMACIE RACOUR DEPREUVE generated a net profit of 22 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE RACOUR DEPREUVE ?
The headquarters of SELARL PHARMACIE RACOUR DEPREUVE is located in ROCROI (08230), in the department Ardennes.
Where to find the tax return of SELARL PHARMACIE RACOUR DEPREUVE ?
The tax return of SELARL PHARMACIE RACOUR DEPREUVE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE RACOUR DEPREUVE operate?
SELARL PHARMACIE RACOUR DEPREUVE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Drehen Sie Ihr Telefon ins Querformat, um das Diagramm anzuzeigen